Mucormycosis in paediatric patients: Demographics, risk factors and outcome of 12 contemporary cases

Mycoses

Volumn 54, Issue 6, 2011, Pages

  Däbritz, Jan ^a   Attarbaschi, Andishe ^b   Tintelnot, Kathrin ^c   Kollmar, Nina ^d   Kremens, Bernhard ^e   Loewenich, Friederike D v ^f   Schrod, Lothar ^g   Schuster, Friedhelm ^h   Wintergerst, Uwe ^h   Weig, Michael ^d   Lehrnbecher, Thomas ⁱ   Groll, Andreas H ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c ROBERT KOCH INSTITUTE   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g SANOFI   (France)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Children; Epidemiology; Mucormycosis; Mycoses; Neonates; Outcome

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CASPOFUNGIN; GLUCOCORTICOID; POSACONAZOLE; VORICONAZOLE;

ABSIDIA; ADOLESCENT; ANTIMICROBIAL THERAPY; ARTICLE; AUSTRIA; BRAIN INFECTION; CASE STUDY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DEBRIDEMENT; FEMALE; GERMANY; HUMAN; HUMAN TISSUE; INFANT; LUNG MYCOSIS; MALE; MEDIASTINUM DISEASE; MUCOR; MUCORMYCOSIS; NEUTROPENIA; NEWBORN; NOSE INFECTION; PARANASAL SINUS; PRESCHOOL CHILD; PRIORITY JOURNAL; RHIZOPUS; SCHOOL CHILD; SOFT TISSUE INFECTION; THROMBUS;

ADOLESCENT; AUSTRIA; CHILD; DEMOGRAPHY; FEMALE; GERMANY; HUMANS; INFANT; MALE; MUCORALES; MUCORMYCOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ABSIDIA; MUCOR; RHIZOPUS;

EID: 80053933359     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02025.x     Document Type: Article

References (13)

1. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48: 1743-51.
2. Petrikkos G, Skiada A, Sambatakou H et al. Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 2003; 22: 753-6.
3. Pagano L, Offidani M, Fianchi L et al. Mucormycosis in hematologic patients. Haematologica 2004; 89: 207-14.
4. Roden MM, Zaoutis TE, Buchanan WL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-53.
5. Bitar D, Van Cauteren D, Lanternier F et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis 2009; 15: 1395-401.
6. Rüping MJ, Heinz WJ, Kindo AJ et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 2010; 65: 296-302.
7. Zaoutis TE, Roilides E, Chiou CC et al. Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J 2007; 26: 723-7.
8. Roilides E, Zaoutis TE, Katragkou A, Benjamin DK Jr, Walsh TJ. Zygomycosis in neonates: an uncommon but life-threatening infection. Am J Perinatol 2009; 26: 565-73.
9. Dehority W, Willert J, Pong A. Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature. J Pediatr Hematol Oncol 2009; 31: 911-9.
10. De Pauw B, Walsh TJ, Donnelly JP. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
11. Skiada A, Pagano L, Groll A et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011. Jan 2, doi:. [Epub ahead of print].
12. Rickerts V, Bohme A, Just-Nubling G. Risk factor for invasive zygomycosis in patients with hematologic malignancies. Mycoses 2002; 45(Suppl. 1): 27-30.
13. Alastruey-Izquierdo A, Hoffmann K, de Hoog GS et al. Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Mycocladus). J Clin Microbiol 2010; 48: 2154-70.